Literature DB >> 7853528

Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.

N L Michael1, T Mo, A Merzouki, M O'Shaughnessy, C Oster, D S Burke, R R Redfield, D L Birx, S A Cassol.   

Abstract

We report the results of a longitudinal study of RNA splicing patterns in 31 early-stage human immunodeficiency virus disease patients with an average follow-up time of 3 years. Eighteen patients showed no evidence for disease progression, whereas 13 patients either showed a > or = 50% reduction in baseline CD4 count or developed opportunistic infections. Levels of unspliced, tat, rev, and nef mRNAs in peripheral blood mononuclear cells were measured by a reverse transcriptase-quantitative, competitive PCR assay. Viral RNA was detected in all patients at all time points. All 13 rapid progressors had viral RNA loads that were > or = 1 log unit greater than those of the slow progressors. In addition, seven of the rapid progressors showed a reduction of more than threefold in the ratio of spliced to unspliced RNA over the 3 years of follow-up. Conversely, two slow progressors with intermediate levels of viral RNA showed no splicing shift. These results confirm earlier observations that viral RNA is uniformly expressed in early-stage patients. We further show that cellular RNA viral load is predictive of disease progression. Importantly, the shift from a predominately spliced or regulatory viral mRNA pattern to a predominately unspliced pattern both is associated with disease progression and adds predictive utility to measurement of either RNA class alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853528      PMCID: PMC188799     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation.

Authors:  M B Feinberg; D Baltimore; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates.

Authors:  L Q Zhang; P Simmonds; C A Ludlam; A J Brown
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

3.  Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease.

Authors:  N L Michael; M Vahey; D S Burke; R R Redfield
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

5.  Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease.

Authors:  S M Schnittman; J J Greenhouse; H C Lane; P F Pierce; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1991-04       Impact factor: 2.205

6.  A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.

Authors:  R R Redfield; D L Birx; N Ketter; E Tramont; V Polonis; C Davis; J F Brundage; G Smith; S Johnson; A Fowler
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

7.  Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient.

Authors:  D Mathez; D Paul; C de Bélilovsky; Y Sultan; J Deleuze; I Gorin; W Saurin; R Decker; J Leibowitch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction.

Authors:  M Holodniy; D A Katzenstein; S Sengupta; A M Wang; C Casipit; D H Schwartz; M Konrad; E Groves; T C Merigan
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

9.  Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes.

Authors:  M E Klotman; S Kim; A Buchbinder; A DeRossi; D Baltimore; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

10.  Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment.

Authors:  D A Katzenstein; M Holodniy; D M Israelski; S Sengupta; L A Mole; J L Bubp; T C Merigan
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
View more
  26 in total

1.  Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

Authors:  M Comar; C Simonelli; S Zanussi; P Paoli; E Vaccher; U Tirelli; M Giacca
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 2.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.

Authors:  Y H Zheng; H Sentsui; T Nakaya; Y Kono; K Ikuta
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.

Authors:  S J Popper; A D Sarr; A Guèye-Ndiaye; S Mboup; M E Essex; P J Kanki
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 5.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

6.  High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA.

Authors:  M Kameoka; T Kimura; Y Okada; K Fujinaga; T Nakaya; H Takahashi; M Kishi; K Ikuta
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

7.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  M Zazzi; L Romano; M Catucci; G Venturi; A De Milito; P E Valensin
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission.

Authors:  Nobubelo K Ngandu; Cathal Seoighe; Konrad Scheffler
Journal:  Virol J       Date:  2009-10-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.